Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil Musilek

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Molecules (Basel, Switzerland)|October 26, 2007
Two step synthesis of a non-symmetric acetylcholinesterase reactivatorKamil Musilek, Kamil Kuca, Vlastimil Dohnal, et al.
Bioorganic & Medicinal Chemistry|August 5, 2008
Monoquaternary pyridinium salts with modified side chain-synthesis and evaluation on model of tabun- and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Jiri Kucera, Daniel Jun, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 13, 2007
Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 26, 2009
A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and miceJiri Kassa, Jana Karasova, Jiri Bajgar, et al.
Neurotoxicology|May 15, 2016
Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitorEvica Antonijevic, Kamil Musilek, Kamil Kuca, et al.
Mini Reviews in Medicinal Chemistry|November 8, 2013
Prophylaxis and post-exposure treatment of intoxications caused by nerve agents and organophosphorus pesticidesKamil Kuca, Daniel Jun, Kamil Musilek, et al.
Current Medicinal Chemistry|January 27, 2015
A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s DiseaseOndrej Benek, Laura Aitken, Lukas Hroch, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 3, 2010
Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesteraseKamil Kuca, Kamil Musilek, Daniel Jun, et al.
Basic & Clinical Pharmacology & Toxicology|January 16, 2009
Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned ratsJiri Kassa, Jana Zdarova Karasova, Jiri Bajgar, et al.
Journal of Neurochemistry|April 20, 2020
Friend or enemy? Review of 17β-HSD10 and its role in human health or diseaseLucie Vinklarova, Monika Schmidt, Ondrej Benek, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Molecules (Basel, Switzerland)|October 26, 2007
Two step synthesis of a non-symmetric acetylcholinesterase reactivatorKamil Musilek, Kamil Kuca, Vlastimil Dohnal, et al.
Bioorganic & Medicinal Chemistry|August 5, 2008
Monoquaternary pyridinium salts with modified side chain-synthesis and evaluation on model of tabun- and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Jiri Kucera, Daniel Jun, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 13, 2007
Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 26, 2009
A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and miceJiri Kassa, Jana Karasova, Jiri Bajgar, et al.
Neurotoxicology|May 15, 2016
Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitorEvica Antonijevic, Kamil Musilek, Kamil Kuca, et al.
Mini Reviews in Medicinal Chemistry|November 8, 2013
Prophylaxis and post-exposure treatment of intoxications caused by nerve agents and organophosphorus pesticidesKamil Kuca, Daniel Jun, Kamil Musilek, et al.
Current Medicinal Chemistry|January 27, 2015
A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s DiseaseOndrej Benek, Laura Aitken, Lukas Hroch, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 3, 2010
Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesteraseKamil Kuca, Kamil Musilek, Daniel Jun, et al.
Basic & Clinical Pharmacology & Toxicology|January 16, 2009
Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned ratsJiri Kassa, Jana Zdarova Karasova, Jiri Bajgar, et al.
Journal of Neurochemistry|April 20, 2020
Friend or enemy? Review of 17β-HSD10 and its role in human health or diseaseLucie Vinklarova, Monika Schmidt, Ondrej Benek, et al.
Pageof 20